This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Teijin Pharma Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Masayuki Tera: Innovator in Pharmaceutical Chemistry
Introduction
Masayuki Tera is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.
Latest Patents
Masayuki Tera holds a patent for a pyrazole derivative. This compound, expressed by a specific formula, is designed to have a pharmacologically permissible salt. It serves as an active ingredient in drugs that inhibit xanthine oxidase, which is crucial for treating or preventing various diseases. These diseases include gout, hyperuricemia, tumor lysis syndrome, urinary tract stones, hypertension, dyslipidemia, diabetes, cardiovascular diseases, renal diseases, respiratory diseases, and autoimmune diseases.
Career Highlights
Tera is associated with Teijin Pharma Limited, where he has been instrumental in advancing pharmaceutical research and development. His work focuses on creating innovative solutions that address significant health challenges.
Collaborations
He has collaborated with notable colleagues, including Asahi Kawana and Chikashi Kanazawa, to further enhance the impact of their research in the pharmaceutical industry.
Conclusion
Masayuki Tera's contributions to pharmaceutical chemistry, particularly through his patented pyrazole derivative, highlight his role as an innovator in the field. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile